Public Profile

Panagene Inc

Panagene Inc., a leading biotechnology firm headquartered in South Korea (KR), has established itself as a key player in the molecular diagnostics industry since its founding in 2000. With a focus on innovative solutions for cancer diagnostics and personalised medicine, Panagene has developed a range of proprietary technologies that enhance the accuracy and efficiency of genetic testing. The company’s core offerings include advanced PCR-based assays and next-generation sequencing (NGS) products, which are distinguished by their high sensitivity and specificity. Panagene's commitment to research and development has positioned it at the forefront of the industry, earning recognition for its contributions to precision oncology. With a strong presence in both domestic and international markets, Panagene continues to drive advancements in molecular diagnostics, making significant strides in improving patient outcomes.

DitchCarbon Score

How does Panagene Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Panagene Inc's score of 0 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Panagene Inc's reported carbon emissions

Panagene Inc, headquartered in South Korea (KR), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints, aligning with broader climate commitments prevalent in the biotechnology sector. As the industry increasingly focuses on sustainability, it is likely that Panagene Inc is exploring strategies to enhance its environmental performance. Further information would be necessary to provide a comprehensive overview of their climate commitments and emissions profile.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Panagene Inc's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Panagene Inc is headquartered in KR, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Panagene Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

TSI INC

US
Medical Device Manufacturing
Updated 10 days ago

Ivd Medical Holding

CN
Medical Device Manufacturing
Updated 10 days ago

Fuji Pharma Co

JP
Medical Device Manufacturing
Updated 10 days ago

Löwenstein Medical

GB
Medical Device Manufacturing
Updated 10 days ago

Abaco Systems Limited

GB
Medical Device Manufacturing
Updated 3 days ago

Humanis

TR
Medical Device Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers